\-\ Texto\\:\\ \ \(0\)\
\-\ no\\ significant\\ physical\\ exam\\ findings\\.\ \(0\)\
\-\ surgical\\ resection\\ and\\ started\\ on\\ chemotherapy\ \(0\)\
\-\ focal\\ wall\\ thickening\\ \\(11mm\\)\\ of\\ a\\ segment\\ of\\ jejunum\\ in\\ the\\ left\\ upper\\ quadrant\\.\\ \\ this\\ segment\\ of\\ jejunum\\ is\\ also\\ dilated\\ with\\ a\\ maximum\\ diameter\\ of\\ 5\\.3\\ cm\\ with\\ retained\\ contrast\\ and\\ an\\ air\\-fluid\\ level\\.\\ \\ also\\ noted\\ is\\ surrounding\\ lymphadenopathy\\ and\\ peritoneal\\ fat\\ stranding\\,\\ the\\ largest\\ mesenteric\\ lymphnode\\ measuring\\ 1\\.3cm\\ in\\ its\\ shortest\\ diameter\\.\ \(0\)\
\-\ non\\-hodgkins\\ lymphoma\\ \\(large\\ b\\-cell\\)\\ of\\ the\\ proximal\\ small\\ bowel\ \(0\)\
\-\ \\<i\\>lymphoma\ \(0\)\
\-\ \\<i\\>adenocarcinoma\ \(0\)\
\-\ \\<i\\>carcinoid\\ tumor\ \(0\)\
\-\ \\<i\\>metastases\ \(0\)\
\-\ active\\ duty\\ soldier\\ with\\ three\\ week\\ history\\ of\\ nausea\\,\\ vomiting\\,\\ and\\ epigastric\\ abdominal\\ pain\\ while\\ deployed\\ in\\ iraq\\.\ \(0\)\
\-\ non\\-hodgkin\\ lymphoma\\ is\\ the\\ most\\ common\\ malignancy\\ of\\ the\\ small\\ bowel\\,\\ representing\\ 20\\%\\ of\\ small\\ bowel\\ malignancies\\.\\ \\ it\\ most\\ often\\ occurs\\ in\\ males\\ between\\ 50\\ to\\ 60\\ years\\ old\\ and\\ occurs\\ most\\ often\\ in\\ the\\ distal\\ ileum\\.\\ \\ prognosis\\ is\\ worse\\ for\\ younger\\ patients\\ and\\ females\\.\\ \\ \\ immunocompromised\\ patients\\ have\\ an\\ increased\\ frequency\\ of\\ non\\-hodgkin\\â\\€\\™s\\ lymphoma\\ of\\ the\\ small\\ bowel\\.\ \(0\)\
\-\ the\\ radiographic\\ appearance\\ of\\ small\\ bowel\\ varies\\ to\\ include\\ fold\\ thickening\\ or\\ effacement\\,\\ luminal\\ narrowing\\,\\ diffuse\\ nodularity\\,\\ extrinsic\\ compression\\ by\\ mesenteric\\ masses\\,\\ and\\ most\\ often\\ marked\\ luminal\\ dilatation\\.\\ \\ lymphoma\\ of\\ the\\ small\\ intestine\\ may\\ also\\ present\\ as\\ an\\ ulcerating\\ mass\\.\\ \\ diagnosis\\ of\\ primary\\ small\\ bowel\\ lymphoma\\ is\\ made\\ by\\ the\\ presence\\ of\\ an\\ isolated\\ small\\ bowel\\ lesion\\ and\\ regional\\ lymphadenopathy\\ without\\ splenic\\,\\ hematologic\\,\\ or\\ hepatic\\ involvment\\.\\ \\ \ \(0\)\
\-\ the\\ differential\\ diagnosis\\ of\\ non\\-hodgkin\\ includes\\ adenocarcinoma\\,\\ carcinoid\\ tumor\\,\\ gastrointestinal\\ stromal\\ tumor\\,\\ lipoma\\,\\ metastases\\,\\ and\\ peutz\\-jeghers\\ syndrome\\.\\ \\ imaging\\ modalities\\ include\\ fluoroscopy\\,\\ ct\\,\\ and\\ mri\\.\ \(0\)\
\-\ the\\ diagnosis\\ can\\ be\\ suggested\\ with\\ imaging\\ when\\ focal\\ thickening\\ of\\ a\\ bowel\\ loop\\ associated\\ with\\ \\"aneurysmal\\ dilatation\\"\\ of\\ the\\ segment\\ and\\ regional\\ lymphadenopathy\\ is\\ seen\\,\\ as\\ on\\ this\\ case\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ bowel\\:\\ 0\\.31736791209780296\ \(0\)\
\-\ small\\:\\ 0\\.255095553783141\ \(0\)\
\-\ lymphoma\\:\\ 0\\.2208927083867025\ \(0\)\
\-\ of\\:\\ 0\\.2056520924650895\ \(0\)\
\-\ the\\:\\ 0\\.16034976704496537\ \(0\)\
\-\ segment\\:\\ 0\\.153113137861633\ \(0\)\
\-\ lymphadenopathy\\:\\ 0\\.14992516580706644\ \(0\)\
\-\ jejunum\\:\\ 0\\.14675336207334785\ \(0\)\
\-\ luminal\\:\\ 0\\.14297454060844822\ \(0\)\
\-\ and\\:\\ 0\\.14050946256889985\ \(0\)\
\-\ regional\\:\\ 0\\.13762425647235715\ \(0\)\
\-\ carcinoid\\:\\ 0\\.13023523624225586\ \(0\)\
\-\ most\\:\\ 0\\.12868435731944983\ \(0\)\
\-\ thickening\\:\\ 0\\.12616399789168387\ \(0\)\
\-\ often\\:\\ 0\\.1210054517078637\ \(0\)\
\-\ mesenteric\\:\\ 0\\.10674811965871167\ \(0\)\
\-\ is\\:\\ 0\\.10157292953022765\ \(0\)\
\-\ adenocarcinoma\\:\\ 0\\.10104927633900936\ \(0\)\
\-\ dilatation\\:\\ 0\\.10092435756652278\ \(0\)\
\-\ metastases\\:\\ 0\\.0999501105380443\ \(0\)\
\-\ diameter\\:\\ 0\\.09936272100887227\ \(0\)\
\-\ shortest\\:\\ 0\\.09885776700612817\ \(0\)\
\-\ occurs\\:\\ 0\\.09747689324008989\ \(0\)\
\-\ tumor\\:\\ 0\\.09700057934885262\ \(0\)\
\-\ diagnosis\\:\\ 0\\.09613543993772343\ \(0\)\
\-\ an\\:\\ 0\\.09455342633854948\ \(0\)\
\-\ ulcerating\\:\\ 0\\.09446387400846962\ \(0\)\
\-\ 11mm\\:\\ 0\\.08892822350141984\ \(0\)\
\-\ also\\:\\ 0\\.08722988818766371\ \(0\)\
\-\ lymphnode\\:\\ 0\\.08695246431598222\ \(0\)\
\-\ hematologic\\:\\ 0\\.08695246431598222\ \(0\)\
\-\ involvment\\:\\ 0\\.08141681380893244\ \(0\)\
\-\ iraq\\:\\ 0\\.07857365793330524\ \(0\)\
\-\ intestine\\:\\ 0\\.07702292081127388\ \(0\)\
\-\ in\\:\\ 0\\.07688948190130207\ \(0\)\
\-\ immunocompromised\\:\\ 0\\.07632353792866597\ \(0\)\
\-\ focal\\:\\ 0\\.07395146759305533\ \(0\)\
\-\ include\\:\\ 0\\.07356030551156063\ \(0\)\
\-\ deployed\\:\\ 0\\.07148727030422411\ \(0\)\
\-\ fold\\:\\ 0\\.07148727030422411\ \(0\)\
\-\ varies\\:\\ 0\\.07106224824081783\ \(0\)\
\-\ patients\\:\\ 0\\.06955013122659731\ \(0\)\
\-\ malignancies\\:\\ 0\\.06951151111878648\ \(0\)\
\-\ fluoroscopy\\:\\ 0\\.06951151111878648\ \(0\)\
\-\ retained\\:\\ 0\\.06915617851429029\ \(0\)\
\-\ soldier\\:\\ 0\\.06881212823617858\ \(0\)\
\-\ nodularity\\:\\ 0\\.06847866581774005\ \(0\)\
\-\ stromal\\:\\ 0\\.06753575193334886\ \(0\)\
\-\ extrinsic\\:\\ 0\\.06666835524315928\ \(0\)\
\-\ modalities\\:\\ 0\\.06612640864312201\ \(0\)\
\-\ maximum\\:\\ 0\\.06561027902614348\ \(0\)\
\-\ imaging\\:\\ 0\\.06497314545167655\ \(0\)\
\-\ younger\\:\\ 0\\.06464638416034171\ \(0\)\
\-\ males\\:\\ 0\\.06376126600501973\ \(0\)\
\-\ loop\\:\\ 0\\.06376126600501973\ \(0\)\
\-\ epigastric\\:\\ 0\\.06355083854833043\ \(0\)\
\-\ largest\\:\\ 0\\.06294301531069028\ \(0\)\
\-\ ileum\\:\\ 0\\.06255595011100558\ \(0\)\
\-\ females\\:\\ 0\\.06218223468019542\ \(0\)\
\-\ effacement\\:\\ 0\\.061300718543691186\ \(0\)\
\-\ gastrointestinal\\:\\ 0\\.06096725612525265\ \(0\)\
\-\ splenic\\:\\ 0\\.0606437493101909\ \(0\)\
\-\ aneurysmal\\:\\ 0\\.0606437493101909\ \(0\)\
\-\ with\\:\\ 0\\.060522049865098015\ \(0\)\
\-\ frequency\\:\\ 0\\.05874796593803174\ \(0\)\
\-\ isolated\\:\\ 0\\.05874796593803174\ \(0\)\
\-\ duty\\:\\ 0\\.058614998950634614\ \(0\)\
\-\ representing\\:\\ 0\\.05848364372400693\ \(0\)\
\-\ peritoneal\\:\\ 0\\.05809886933365608\ \(0\)\
\-\ suggested\\:\\ 0\\.05784973943042382\ \(0\)\
\-\ stranding\\:\\ 0\\.055333535505323224\ \(0\)\
\-\ prognosis\\:\\ 0\\.05439876031715645\ \(0\)\
\-\ lipoma\\:\\ 0\\.05362129504362211\ \(0\)\
\-\ by\\:\\ 0\\.05250159668343608\ \(0\)\
\-\ started\\:\\ 0\\.05207055792159075\ \(0\)\
\-\ worse\\:\\ 0\\.051785365843602923\ \(0\)\
\-\ as\\:\\ 0\\.049667626227839254\ \(0\)\
\-\ hepatic\\:\\ 0\\.04922740204596354\ \(0\)\
\-\ includes\\:\\ 0\\.048068985542494606\ \(0\)\
\-\ narrowing\\:\\ 0\\.04792019592571548\ \(0\)\
\-\ measuring\\:\\ 0\\.04782212581283583\ \(0\)\
\-\ made\\:\\ 0\\.0476766649239322\ \(0\)\
\-\ nausea\\:\\ 0\\.04748570538332026\ \(0\)\
\-\ marked\\:\\ 0\\.046753837557828457\ \(0\)\
\-\ malignancy\\:\\ 0\\.0462778991587164\ \(0\)\
\-\ 60\\:\\ 0\\.04623565086538562\ \(0\)\
\-\ active\\:\\ 0\\.045903466281217\ \(0\)\
\-\ radiographic\\:\\ 0\\.04586265013686844\ \(0\)\
\-\ its\\:\\ 0\\.04574111607596052\ \(0\)\
\-\ vomiting\\:\\ 0\\.04574111607596052\ \(0\)\
\-\ compression\\:\\ 0\\.04526816799408351\ \(0\)\
\-\ presence\\:\\ 0\\.04441561403120194\ \(0\)\
\-\ dilated\\:\\ 0\\.044273956151115526\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.043893682975165195\ \(0\)\
\-\ quadrant\\:\\ 0\\.043298838161260136\ \(0\)\
\-\ 50\\:\\ 0\\.04317097032356073\ \(0\)\
\-\ or\\:\\ 0\\.04300960004224379\ \(0\)\
\-\ this\\:\\ 0\\.042482407507653995\ \(0\)\
\-\ masses\\:\\ 0\\.04208337240058442\ \(0\)\
\-\ week\\:\\ 0\\.041577943690246894\ \(0\)\
\-\ three\\:\\ 0\\.04149595081348871\ \(0\)\
\-\ surrounding\\:\\ 0\\.041227036927557546\ \(0\)\
\-\ between\\:\\ 0\\.0401652552314448\ \(0\)\
\-\ differential\\:\\ 0\\.0401652552314448\ \(0\)\
\-\ while\\:\\ 0\\.039950660624727824\ \(0\)\
\-\ 20\\:\\ 0\\.03988006315345697\ \(0\)\
\-\ resection\\:\\ 0\\.03962507083541392\ \(0\)\
\-\ diffuse\\:\\ 0\\.038766489466228994\ \(0\)\
\-\ proximal\\:\\ 0\\.03861933547935872\ \(0\)\
\-\ fat\\:\\ 0\\.03845357051084041\ \(0\)\
\-\ primary\\:\\ 0\\.03801037339735689\ \(0\)\
\-\ years\\:\\ 0\\.0378925823081275\ \(0\)\
\-\ wall\\:\\ 0\\.03760358722132245\ \(0\)\
\-\ level\\:\\ 0\\.03734063943478549\ \(0\)\
\-\ when\\:\\ 0\\.03734063943478549\ \(0\)\
\-\ on\\:\\ 0\\.03733918464060015\ \(0\)\
\-\ appearance\\:\\ 0\\.03726666867990344\ \(0\)\
\-\ syndrome\\:\\ 0\\.03726666867990344\ \(0\)\
\-\ distal\\:\\ 0\\.03591682312268987\ \(0\)\
\-\ significant\\:\\ 0\\.035691386420507766\ \(0\)\
\-\ cm\\:\\ 0\\.035501818784529876\ \(0\)\
\-\ common\\:\\ 0\\.03505693885811376\ \(0\)\
\-\ abdominal\\:\\ 0\\.03380898992282859\ \(0\)\
\-\ physical\\:\\ 0\\.03351823246006405\ \(0\)\
\-\ increased\\:\\ 0\\.03342733113065728\ \(0\)\
\-\ upper\\:\\ 0\\.03303368869671306\ \(0\)\
\-\ noted\\:\\ 0\\.03277492694960677\ \(0\)\
\-\ without\\:\\ 0\\.032605789258369294\ \(0\)\
\-\ associated\\:\\ 0\\.032581840798869104\ \(0\)\
\-\ can\\:\\ 0\\.03243925093224043\ \(0\)\
\-\ mri\\:\\ 0\\.03173101817285366\ \(0\)\
\-\ present\\:\\ 0\\.03171996598065298\ \(0\)\
\-\ it\\:\\ 0\\.031642914650866404\ \(0\)\
\-\ exam\\:\\ 0\\.03111837077419893\ \(0\)\
\-\ may\\:\\ 0\\.031107925786871323\ \(0\)\
\-\ case\\:\\ 0\\.031055851330520495\ \(0\)\
\-\ large\\:\\ 0\\.03097304921982671\ \(0\)\
\-\ to\\:\\ 0\\.030907921486062726\ \(0\)\
\-\ have\\:\\ 0\\.03088064689624221\ \(0\)\
\-\ findings\\:\\ 0\\.030508837667751653\ \(0\)\
\-\ surgical\\:\\ 0\\.03004475218612453\ \(0\)\
\-\ contrast\\:\\ 0\\.03003529197294107\ \(0\)\
\-\ lesion\\:\\ 0\\.029636123110401192\ \(0\)\
\-\ seen\\:\\ 0\\.02910262702574209\ \(0\)\
\-\ be\\:\\ 0\\.02507641326138509\ \(0\)\
\-\ history\\:\\ 0\\.0236174161462113\ \(0\)\
\-\ mass\\:\\ 0\\.02361218735309975\ \(0\)\
\-\ ct\\:\\ 0\\.023534056708140644\ \(0\)\
\-\ pain\\:\\ 0\\.022120157322192514\ \(0\)\
\-\ left\\:\\ 0\\.021086897925595354\ \(0\)\
\-\ no\\:\\ 0\\.020101966694153723\ \(0\)\
\-\ for\\:\\ 0\\.018736054801023014\ \(0\)\
\-\ old\\:\\ 0\\.018295146941093562\ \(0\)\
